<DOC>
	<DOCNO>NCT00652483</DOCNO>
	<brief_summary>This study evaluate safety efficacy brimonidine 0.1 % ophthalmic solution compare brimonidine 0.2 % ophthalmic solution patient glaucoma ocular hypertension</brief_summary>
	<brief_title>Safety Efficacy Study Brimonidine Patients With Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Ocular hypertension glaucoma eye Uncontrolled systemic disease Known allergy sensitivity brimonidine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>